Thioredoxin as a putative biomarker and candidate target in age-related immune decline

Research output: Contribution to journalArticle

View graph of relations Save citation

Authors

Research units

Abstract

The oxidoreductase Trx-1 (thioredoxin 1) is highly conserved and found intra- and extra-cellularly in mammalian systems. There is increasing interest in its capacity to regulate immune function based on observations of altered distribution and expression during ageing and disease. We have investigated previously whether extracellular T-cell or peripheral blood mononuclear cell Trx-1 levels serve as a robust marker of ageing. In a preliminary study of healthy older adults compared with younger adults, we showed that therewas a significant, butweak, relationshipwith age. Interestingly, patientswith rheumatoid arthritis and cancer have been described by others to secrete or express greater surface Trx-1 than predicted. It is interesting to speculate whether a decline in Trx-1 during ageing protects against such conditions, but correspondingly increases risk of disease associated with Trx-1 depletion such as cardiovascular disease. These hypotheses are being explored in the MARK-AGE study, and preliminary findings confirm an inverse correlation of surface Trx-1 with age. We review recent concepts around the role of Trx-1 and its partners in T-cell function on the cell surface and as an extracellular regulator of redox state in a secreted form. Further studies on the redox state and binding partners of surface and secreted Trx-1 in larger patient datasets are needed to improve our understanding of why Trx-1 is important for lifespan and immune function. © The Authors Journal compilation © 2014 Biochemical Society.

Details

Original languageEnglish
Pages (from-to)922-927
Number of pages6
JournalBiochemical Society Transactions
Volume42
Issue number4
DOIs
Publication statusPublished - 31 Aug 2014

    Keywords

  • ageing, oxidation, reactive oxygen species (ROS), rheumatoid arthritis, thiol, thioredoxin

DOI

Employable Graduates; Exploitable Research

Copy the text from this field...